Biomark Diagnostics Inc (BUX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 3 | 3 | N/A | N/A | N/A |
| Accounts receivable | 4 | -2 | 0 | -3 | 5 |
| Other Working Capital | -21 | -42 | -84 | -11 | -7 |
| Other Operating Activity | -192 | -116 | -433 | 367 | -328 |
| Operating Cash Flow | $-205 | $-157 | $-517 | $352 | $-330 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | 0 | -3 | N/A | N/A | N/A |
| Investing Cash Flow | $0 | $-3 | $0 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -4 | -4 | N/A | N/A | N/A |
| Common Stock Issued | 83 | 0 | -4 | 652 | 0 |
| Other Financing Activity | 76 | 57 | 408 | -345 | 240 |
| Financing Cash Flow | $155 | $54 | $404 | $308 | $240 |
| Beginning Cash Position | 505 | 612 | 725 | 65 | 155 |
| End Cash Position | 455 | 505 | 612 | 725 | 65 |
| Net Cash Flow | $-51 | $-107 | $-113 | $659 | $-90 |
| Free Cash Flow | |||||
| Operating Cash Flow | -205 | -157 | -517 | 352 | -330 |
| Free Cash Flow | -205 | -157 | -517 | 352 | -330 |